Aurobindo Pharma (₹1,217.45)
Fresh breakout expected
Since January, the stock of Aurobindo Pharma has been charting a sideways trend. It has been oscillating between ₹1,020 and ₹1,250. Over the past few weeks, the stock has been hovering near the resistance at ₹1,250. The price action indicates a bullish undertone and so, the stock is likely to break out of ₹1,250.
Such a breach can open the door for a rally to ₹1,800. So, we suggest buying the stock at ₹1,215 and accumulate at ₹1,150. Stop-loss can be ₹980. When the stock touches ₹1,500, move the stop-loss up to ₹1,400. On a rally to ₹1,650, alter the stop-loss to ₹1,580. Exit at ₹1,800.
Bharat Forge (₹1,405.10)
Forms higher high
The stock has been in an uptrend since April. The price is now above 20- and 50-day moving averages and the daily chart shows that the stock has formed higher high and higher low, which are bullish indications. So, broadly, the outlook is positive. While there might be some moderation in price, possibly to ₹1,350, the stock can eventually resume the rally and appreciate to ₹1,800.
Go long on the stock now at ₹1,405 and buy more shares at ₹1,350. Stop-loss can be ₹1,175. Trail the stop-loss to ₹1,500 when the price rises to ₹1,625. On a rally to ₹1,725, revise the stop-loss to ₹1,650. Exit at ₹1,800.
Gravita India (₹1,796.55)
Gaining traction
The stock has been moving up gradually over the last few weeks. The recovery has been on the back of a key support at ₹1,550. While there is a resistance ahead at ₹1,900, the price action hints that the stock is gaining traction. We expect it to surpass ₹1,900 soon and set off for a rally to ₹2,600 over the medium-term.
Therefore, we suggest buying the stock of Gravita India now at ₹1,796 and accumulate if the price dips to ₹1,700. Place stop-loss at ₹1,525. When the stock rises to ₹2,200, revise the stop-loss to ₹2,080. Alter the stop-loss to ₹2,300 when the price touches ₹2,400. Exit at ₹2,600.
Published on December 6, 2025
